Lantern in the News
Lantern Pharma: Precision Medicine Pioneers
Lantern Pharma: Precision Medicine Pioneers According to a recent study, the overall success rate for drugs moving through [...]
Press Releases
Videos
Company Overview
Lantern Culture
RADR™ Overview
The Science Behind Lantern
4-D Pipeline
3-C Oncology Treatments
5-E Market Opportunity
AI for Precision Medicine
Partnerships and Collaborations
Media Contacts
Contact: Kyle Evans – FischtankPR
Email: lantern@fischtankpr.com
Office: 646-699-1414
Direct: 646-699-1536
Social Media
Recent Tweets
Our AI platform, RADR™, analyzes over 77 million oncology-specific, tumor-drug interaction data points to integrate… twitter.com/i/web/status/1…
7 days agoLantern Pharma CSO Gregory Tobin will be at the @C_TRIC #TMED10 Conference on September 11 in Derry, Ireland discus… twitter.com/i/web/status/1…
2 weeks agoCheck out our newly-launched website! lanternpharma.com pic.twitter.com/RZkfczEyll
2 weeks ago